Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GE Healthcare misses out in US Medicare decision on ICDs (Implantable cardioverter defibrillators) coverage

This article was originally published in Clinica

Executive Summary

US Medicare has finalised its plans to cover a test that will help doctors decide which patients are candidates for an implantable cardioverter defibrillator (ICD). But the federal health plan has said that it will pay only for one version of the test, a product manufactured by tiny company Cambridge Heart, and not a second version made by GE Healthcare. The $400 test, known as microvolt T-wave alternans, detects extremely subtle electrical activity in the T-wave found on an electrocardiogram. Electrodes placed on a patient's chest detect beat-to-beat changes in the T-wave during a period of mild exercise. Software then analyses these microvolt changes, and produces a report to be interpreted by a physician. If the test is positive, the patient is considered to be at risk for sudden cardiac death and recommended for a defibrillator. If the test is negative, patients are at a very low risk of experiencing a life-threatening, irregular heart beat within two years.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT051241

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel